• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Central nervous system side effects of ganciclovir.

作者信息

Davis C L, Springmeyer S, Gmerek B J

出版信息

N Engl J Med. 1990 Mar 29;322(13):933-4. doi: 10.1056/NEJM199003293221315.

DOI:10.1056/NEJM199003293221315
PMID:2156162
Abstract
摘要

相似文献

1
Central nervous system side effects of ganciclovir.
N Engl J Med. 1990 Mar 29;322(13):933-4. doi: 10.1056/NEJM199003293221315.
2
Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients.更昔洛韦与静脉注射免疫球蛋白联合治疗小儿肝移植受者巨细胞病毒感染
Transplantation. 1991 Jul;52(1):151-4.
3
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.一项随机对照试验，比较更昔洛韦与更昔洛韦加膦甲酸钠（各用半量）对移植受者巨细胞病毒感染进行抢先治疗的效果。
J Infect Dis. 2004 Apr 15;189(8):1355-61. doi: 10.1086/383040. Epub 2004 Apr 1.
4
Granulocyte macrophage colony-stimulating factor for the therapy of cytomegalovirus and ganciclovir-induced leukopenia in a renal transplant recipient.粒细胞巨噬细胞集落刺激因子用于治疗肾移植受者的巨细胞病毒和更昔洛韦诱导的白细胞减少症。
Transplantation. 1992 Apr;53(4):930-2.
5
Use of ganciclovir in the treatment of cytomegalovirus infections.更昔洛韦在巨细胞病毒感染治疗中的应用。
Br J Clin Pract. 1989 Jul;43(7):233-7.
6
Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal.更昔洛韦治疗巨细胞病毒感染的批判性评价。
Curr Clin Top Infect Dis. 1992;12:309-28.
7
Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.使用高剂量更昔洛韦治疗因 UL97 突变导致的耐巨细胞病毒感染。
Transpl Infect Dis. 2008 Apr;10(2):129-32. doi: 10.1111/j.1399-3062.2007.00249.x. Epub 2007 Jul 1.
8
[Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection].不同剂量更昔洛韦治疗新生儿先天性巨细胞病毒感染的疗效比较
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Aug;11(8):641-4.
9
Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection.
Am J Pediatr Hematol Oncol. 1993 Aug;15(3):320-3.
10
Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients.更昔洛韦早期治疗肾移植受者巨细胞病毒感染的疗效
Transplant Proc. 1990 Aug;22(4):1813-4.

引用本文的文献

1
Discovery of Novel Pyrido[2,3-b]Pyrazine Human Cytomegalovirus Polymerase Inhibitors with Broad Spectrum Antiherpetic Activity and Reduced hERG Inhibition.具有广谱抗疱疹活性且降低人醚-去极化激活的钾离子通道（hERG）抑制作用的新型吡啶并[2,3 - b]吡嗪类人巨细胞病毒聚合酶抑制剂的发现
ChemMedChem. 2025 Mar 15;20(6):e202400629. doi: 10.1002/cmdc.202400629. Epub 2024 Dec 27.
2
Polymer-Based Nanoparticles as Drug Delivery Systems for Purines of Established Importance in Medicine.基于聚合物的纳米颗粒作为医学上已确立重要性的嘌呤类药物递送系统。
Nanomaterials (Basel). 2023 Sep 26;13(19):2647. doi: 10.3390/nano13192647.
3
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients.
肺移植受者中更昔洛韦的药代动力学及基于协变量的个体化给药
Pharmaceutics. 2022 Feb 13;14(2):408. doi: 10.3390/pharmaceutics14020408.
4
Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety.更昔洛韦治疗药物监测与临床疗效及患者安全性的关系。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.01855-18. Print 2019 Mar.
5
Antimicrobial-induced cognitive side effects.抗菌药物引起的认知副作用。
Ment Health Clin. 2016 Jun 29;6(4):207-214. doi: 10.9740/mhc.2016.07.207. eCollection 2016 Jul.
6
A case of severe ganciclovir-induced encephalopathy.1例严重的更昔洛韦诱导的脑病。
Case Rep Neurol. 2013 Oct 5;5(3):183-6. doi: 10.1159/000355638. eCollection 2013.
7
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.伐昔洛韦在成人实体器官移植受者中的应用：药代动力学和药效学特征及血药浓度测定的临床解读。
Clin Pharmacokinet. 2009;48(6):399-418. doi: 10.2165/00003088-200948060-00006.
8
New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.实体器官移植受者巨细胞病毒感染及疾病的预防和治疗新策略。
Clin Microbiol Rev. 2000 Jan;13(1):83-121, table of contents. doi: 10.1128/CMR.13.1.83.
9
Infections in solid-organ transplant recipients.实体器官移植受者的感染
Clin Microbiol Rev. 1997 Jan;10(1):86-124. doi: 10.1128/CMR.10.1.86.
10
Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis.膦甲酸可穿透血脑屏障：治疗巨细胞病毒性脑炎的理论依据。
Antimicrob Agents Chemother. 1993 May;37(5):1010-4. doi: 10.1128/AAC.37.5.1010.